| HOME >> MEDICINE >> TECHNOLOGY |
corresponding Graph/Chart) 120
Table 63: Rest of Europe Historic Review for Antibiotics by
Product Segment - Penicillin, Cephalosporin,
Macrolides, Quinolones, Carbapenems and Other Antibiotics
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 121
Table 64: Rest of Europe 11-Year Perspective for Antibiotics
by Product Segment - Percentage Breakdown of Dollar Sales
for Penicillin, Cephalosporin, Macrolides, Quinolones,
Carbapenems and Other Antibiotics Markets for 2005, 2010 &
2015 (includes corresponding Graph/Chart) 122
18. ASIA-PACIFIC 123
A. Market Analysis 123
Current and Future Analysis 123
India 123
Rising Prices of Penicillin G to Affect Antibiotics Production 123
Market for Injectable Antibiotics Poised to Grow 123
Cipla, Pharmaceutical Market Leader in 2009 124
China 124
Carbapenem Witnesses Robust Growth in China 124
Key Players 125
Ranbaxy Laboratories Ltd. (India) 125
B. Market Analytics 126
Table 65: Asia-Pacific Recent Past, Current & Future
Analysis for Antibiotics by Product Segment - Penicillin,
Cephalosporin, Macrolides, Quinolones, Carbapenems and Other
Antibiotics Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 126
Table 66: Asia-Pacific Historic Review for Antibiotics by
Product Segment - Penicillin, Cephalosporin,
Macrolides, Quinolones, Carbapenems and Other Antibiotics
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 127
Table 67: Asia-Pacific 11-Year Perspective for Antibiotics
by Product Segment - Percentage Breakd
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |